Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00118391 · ClinicalTrials.gov registry record · Phase 1
Cognitive-Behavioral Treatment of Gambling
A Phase 1 study, sponsored by UConn Health.
- Completed
- Registry status
- Phase 1
- Development phase
- 120
- Enrollment target
NCT00118391: Completed Phase 1 study, sponsored by UConn Health.
NCT00118391 is a Phase 1 study that has completed, run by UConn Health. The registered enrollment target is 120 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (100% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00118391, a Phase 1 study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 120 participants
- Enrollment target
Study Summary
This study will determine the effectiveness of cognitive behavior therapy (CBT) and contingency management (CM) in reducing gambling behaviors and other related problems in pathological gambling. Study hypothesis: Participants who receive CBT and CM will attend more treatment sessions and show better outcomes than those who receive CBT alone.
Interventions
- BEHAVIORAL Contingency management
- BEHAVIORAL Cognitive behavior therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2002-11 |
| Est. Completion | 2005-10 |
| Phase | Phase 1 |
What the finished NCT00118391 record still lists
NCT00118391 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (100% higher).
The record links to 0 conditions, and to 2 interventions - of which Contingency management is the first listed.
NCT00118391 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00118391 about?
NCT00118391 is a clinical study titled "Cognitive-Behavioral Treatment of Gambling". This study will determine the effectiveness of cognitive behavior therapy (CBT) and contingency management (CM) in reducing gambling behaviors and other related problems in pathological gambling. Study hypothesis: Participants who receive CBT and CM will attend more treatment sessions and show bett...
What is the current status of trial NCT00118391?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 120 participants. The study started on 2002-11. Estimated completion is 2005-10.
What interventions are being tested in trial NCT00118391?
The interventions under investigation include: Contingency management (BEHAVIORAL), Cognitive behavior therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00118391?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00118391's enrollment target sits among peer trials
120 479th of 2000 higher than 1,503 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia